The document is an intimation of a scheduled Analyst/Investor meeting, filed in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The event is an in-person meeting with Taksh Asset Management, scheduled for Thursday, June 11, 2026, from 05:00 P.M to 06:00 P.M IST in Chennai.
The stated purpose of the meeting is not explicitly detailed beyond being a meeting with Analysts/Institutional Investors.
The intimation includes a note that the meeting is subject to changes due to exigencies on the part of the Analysts/Investors.
A presentation for the meeting is referenced and will be available at the provided link: STARHEALTH29042026111712_ECPresentationQ4FY26V2.pdf. The presentation title suggests it pertains to Q4 FY26 earnings.
The disclosure will also be available on the company's website at www.starhealth.in.
The letter is signed by Jayashree Sethuraman, who is identified as the Company Secretary & Compliance Officer.
The document does not contain any financial highlights, guidance, or forward-looking statements. It is purely a scheduling intimation.
There is no explicit statement regarding the sharing of Unpublished Price Sensitive Information (UPSI).
Additional Notes Section
The document is a formal letter addressed to the Listing Departments of BSE Limited and the National Stock Exchange of India Limited.
It carries a reference number: SHAI/B & S/SE/35/2026-27.
No financial data or strategic updates were disclosed in this announcement.
The presentation linked appears to be an earnings deck for Q4 FY26, but it is an external document not included in this filing.
